Ultrasis (LSE:ULT) Total Receivables: £1.11 Mil (As of Jul. 2014)


What is Ultrasis Total Receivables?

Ultrasis LSE:ULT Total Receivables is £1.11 Mil as of Jul. 2014. The stock has 2 warning signs investors should review.

Ultrasis's Total Receivables for the quarter that ended in Jul. 2014 was £1.11 Mil.

Ultrasis Total Receivables Historical Data

* Premium members only.

The historical data trend for Ultrasis's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ultrasis Total Receivables Chart

Ultrasis Annual Data
Trend Jul05 Jul06 Jul07 Jul08 Jul09 Jul10 Jul11 Jul12 Jul13 Jul14
Total Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.61 0.97 0.30 0.21 1.11

Ultrasis Semi-Annual Data
Jul96 Jul97 Jul98 Jul99 Jul00 Jul01 Jul02 Jul03 Jul04 Jul05 Jul06 Jul07 Jul08 Jul09 Jul10 Jul11 Jul12 Jul13 Jul14
Total Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.61 0.97 0.30 0.21 1.11

Ultrasis Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables

Frequently Asked Questions Learn more about Total Receivables →
What does a Total Receivables of £1.11 Mil mean?
Ultrasis (LSE:ULT) has a Total Receivables of £1.11 Mil as of Jul. 2014. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Ultrasis and its competitors.
Is Ultrasis' Total Receivables too high?
Ultrasis' current Total Receivables is £1.11 Mil.
How does Ultrasis' Total Receivables compare to competitors?
Ultrasis' Total Receivables of £1.11 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Receivables for a Healthcare Providers & Services company?
A good Total Receivables depends on the Healthcare Providers & Services industry context. However, Total Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Receivables mean?
A high Total Receivables can signal that a stock is expensive relative to its fundamentals. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Ultrasis and its competitors. Ultrasis's current Total Receivables is £1.11 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ultrasis stock overvalued right now?
Ultrasis (LSE:ULT) has a current Total Receivables of £1.11 Mil. The current Total Receivables is £1.11 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Receivables calculated?
Total Receivables is calculated from a company's financial statements. For Ultrasis (LSE:ULT), the current Total Receivables is £1.11 Mil as of Jul. 2014. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ultrasis Business Description

Ultrasis PLC was incorporated in November 23, 1981. The Company through its subsidiary provides healthcare products and services provided via the medium of technology or face to face, that help people maintain, regain and improve their physical, psychological and social well-being. Its product includes Beating the Blues(r), GetFit Wellness, My Brain Solutions, The Relief Series, Drink & Drug Wise, Calm Workplace, and Optimise Me, Screenetics and Joggle.